Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-016912
Filing Date
2021-08-13
Accepted
2021-08-13 08:03:19
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20210630.htm   iXBRL 10-Q 1622941
2 EX-31.1 ardx-20210630xex311.htm EX-31.1 8416
3 EX-31.2 ardx-20210630xex312.htm EX-31.2 8404
4 EX-32.1 ardx-20210630xex321.htm EX-32.1 5705
10 ardx-20210630_g1.jpg GRAPHIC 75659
  Complete submission text file 0001628280-21-016912.txt   6745282

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20210630.xsd EX-101.SCH 41617
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20210630_cal.xml EX-101.CAL 58207
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20210630_def.xml EX-101.DEF 221331
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20210630_lab.xml EX-101.LAB 566850
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20210630_pre.xml EX-101.PRE 357939
11 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20210630_htm.xml XML 1017372
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 211169791
SIC: 2834 Pharmaceutical Preparations